Global Benign Prostatic Hyperplasia (BPH) Drugs Market Survey and Trend Research 2018
Summary
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
- Raw Materials
- Cost
- Technology
- Consumer Preference
- History
- Development & Trend
- Market Competition
- Trade Overview
- Policy
- Regional Market
- Production Development
- Sales
- Regional Trade
- Regional Forecast
- Company Profile
- Product & Service
- Business Operation Data
- Market Share
- Market Features
- Investment Opportunity
- Investment Calculation
PART 1 INDUSTRY OVERVIEW
1.1 Benign Prostatic Hyperplasia (BPH) Drugs Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
PART 2 INDUSTRY OVERALL
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
PART 3 BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS MARKET BY PRODUCT
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
4 KEY COMPANIES LIST
4.1 Astellas Pharma (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Eli Lilly (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 GlaxoSmithKline (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 Sanofi (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 Bayer HealthCare (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 Bayer HealthCare (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 Bristol-Myers Squibb (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
4.8 Valeant Pharmaceuticals (Company Overview, Sales Data etc.)
4.8.1 Company Overview
4.8.2 Products and Services
4.8.3 Business Analysis
4.9 Endo Pharmaceuticals (Company Overview, Sales Data etc.)
4.9.1 Company Overview
4.9.2 Products and Services
4.9.3 Business Analysis
4.10 Foresee Pharmaceuticals (Company Overview, Sales Data etc.)
4.10.1 Company Overview
4.10.2 Products and Services
4.10.3 Business Analysis
4.11 Madrigal Pharmaceuticals (Company Overview, Sales Data etc.)
4.12 Merck (Company Overview, Sales Data etc.)
4.13 Novartis (Company Overview, Sales Data etc.)
4.14 Spectrum Pharmaceuticals (Company Overview, Sales Data etc.)
4.15 Takeda Pharmaceuticals (Company Overview, Sales Data etc.)
4.16 Teva (Company Overview, Sales Data etc.)
4.17 Advaxis (Company Overview, Sales Data etc.)
4.18 ANI Pharmaceuticals (Company Overview, Sales Data etc.)
4.19 BHR Pharma (Company Overview, Sales Data etc.)
PART 5 MARKET COMPETITION
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
PART 6 MARKET DEMAND BY SEGMENT
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
PART 7 REGION OPERATION
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
PART 8 MARKET INVESTMENT
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
PART 9 CONCLUSION
1.1 Benign Prostatic Hyperplasia (BPH) Drugs Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
PART 2 INDUSTRY OVERALL
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
PART 3 BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS MARKET BY PRODUCT
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
4 KEY COMPANIES LIST
4.1 Astellas Pharma (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Eli Lilly (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 GlaxoSmithKline (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 Sanofi (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 Bayer HealthCare (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 Bayer HealthCare (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 Bristol-Myers Squibb (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
4.8 Valeant Pharmaceuticals (Company Overview, Sales Data etc.)
4.8.1 Company Overview
4.8.2 Products and Services
4.8.3 Business Analysis
4.9 Endo Pharmaceuticals (Company Overview, Sales Data etc.)
4.9.1 Company Overview
4.9.2 Products and Services
4.9.3 Business Analysis
4.10 Foresee Pharmaceuticals (Company Overview, Sales Data etc.)
4.10.1 Company Overview
4.10.2 Products and Services
4.10.3 Business Analysis
4.11 Madrigal Pharmaceuticals (Company Overview, Sales Data etc.)
4.12 Merck (Company Overview, Sales Data etc.)
4.13 Novartis (Company Overview, Sales Data etc.)
4.14 Spectrum Pharmaceuticals (Company Overview, Sales Data etc.)
4.15 Takeda Pharmaceuticals (Company Overview, Sales Data etc.)
4.16 Teva (Company Overview, Sales Data etc.)
4.17 Advaxis (Company Overview, Sales Data etc.)
4.18 ANI Pharmaceuticals (Company Overview, Sales Data etc.)
4.19 BHR Pharma (Company Overview, Sales Data etc.)
PART 5 MARKET COMPETITION
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
PART 6 MARKET DEMAND BY SEGMENT
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
PART 7 REGION OPERATION
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
PART 8 MARKET INVESTMENT
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
PART 9 CONCLUSION
LIST OF TABLES
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market 2012-2017, by Type, in USD Million
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market 2012-2017, by Type, in Volume
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2018-2023, by Type, in USD Million
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2018-2023, by Type, in Volume
Table Astellas Pharma Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer HealthCare Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Bayer HealthCare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer HealthCare Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Bayer HealthCare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Valeant Pharmaceuticals Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Valeant Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Endo Pharmaceuticals Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Endo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Foresee Pharmaceuticals Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Foresee Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Madrigal Pharmaceuticals Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Madrigal Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Spectrum Pharmaceuticals Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Spectrum Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Takeda Pharmaceuticals Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Takeda Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Advaxis Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Advaxis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ANI Pharmaceuticals Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of ANI Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BHR Pharma Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of BHR Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Revenue Share, by Companies, in USD Million
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume 2012-2017, by Companies, in Volume
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Revenue Share, by Companies in 2017, in Volume
Table Benign Prostatic Hyperplasia (BPH) Drugs Demand 2012-2017, by Application, in USD Million
Table Benign Prostatic Hyperplasia (BPH) Drugs Demand 2012-2017, by Application, in Volume
Table Benign Prostatic Hyperplasia (BPH) Drugs Demand Forecast 2018-2023, by Application, in USD Million
Table Benign Prostatic Hyperplasia (BPH) Drugs Demand Forecast 2018-2023, by Application, in Volume
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market 2012-2017, by Region, in USD Million
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market 2012-2017, by Region, in Volume
Table Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2018-2023, by Region, in USD Million
Table Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2018-2023, by Region, in Volume
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market 2012-2017, by Type, in USD Million
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market 2012-2017, by Type, in Volume
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2018-2023, by Type, in USD Million
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2018-2023, by Type, in Volume
Table Astellas Pharma Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer HealthCare Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Bayer HealthCare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer HealthCare Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Bayer HealthCare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Valeant Pharmaceuticals Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Valeant Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Endo Pharmaceuticals Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Endo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Foresee Pharmaceuticals Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Foresee Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Madrigal Pharmaceuticals Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Madrigal Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Spectrum Pharmaceuticals Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Spectrum Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Takeda Pharmaceuticals Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Takeda Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Advaxis Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of Advaxis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ANI Pharmaceuticals Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of ANI Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BHR Pharma Overview List
Table Benign Prostatic Hyperplasia (BPH) Drugs Business Operation of BHR Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Revenue Share, by Companies, in USD Million
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume 2012-2017, by Companies, in Volume
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Revenue Share, by Companies in 2017, in Volume
Table Benign Prostatic Hyperplasia (BPH) Drugs Demand 2012-2017, by Application, in USD Million
Table Benign Prostatic Hyperplasia (BPH) Drugs Demand 2012-2017, by Application, in Volume
Table Benign Prostatic Hyperplasia (BPH) Drugs Demand Forecast 2018-2023, by Application, in USD Million
Table Benign Prostatic Hyperplasia (BPH) Drugs Demand Forecast 2018-2023, by Application, in Volume
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market 2012-2017, by Region, in USD Million
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market 2012-2017, by Region, in Volume
Table Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2018-2023, by Region, in USD Million
Table Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast 2018-2023, by Region, in Volume
LIST OF FIGURES
Figure Benign Prostatic Hyperplasia (BPH) Drugs Industry Chain Structure
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market Growth 2012-2017, by Type, in USD Million
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market Growth 2012-2017, by Type, in Volume
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region
Figure Benign Prostatic Hyperplasia (BPH) Drugs Industry Chain Structure
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market Growth 2012-2017, by Type, in USD Million
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market Growth 2012-2017, by Type, in Volume
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region
